Building Regulatory Systems That Deliver Better Public Health Outcomes
The rapid evolution of nicotine products has transformed the regulatory landscape. Traditional combustible tobacco products now exist alongside nicotine pouches, electronic cigarettes, heated tobacco products, nicotine replacement therapies, and emerging nicotine technologies. This growing diversity presents governments with an increasingly complex challenge: how can regulatory systems protect public health while remaining responsive to scientific evidence, technological innovation, and changing consumer behaviour?
The answer lies in governance.
Good nicotine governance is about far more than introducing new laws or restricting products. It is about building regulatory systems that are transparent, evidence-based, enforceable, and capable of adapting as knowledge and markets evolve.
For GINN, effective nicotine governance should not be measured solely by the number of regulations enacted or products prohibited. It should be measured by whether policies reduce smoking, protect young people, improve product quality, support informed decision-making, and strengthen public confidence in regulatory institutions.
Science Must Remain the Foundation
Public policy is most effective when it is grounded in robust scientific evidence.
Nicotine regulation should be informed by the best available research on product characteristics, patterns of use, toxicology, consumer behaviour, and population-level health outcomes. As evidence evolves, regulatory frameworks should also evolve rather than remaining fixed to assumptions developed decades earlier.
This does not mean waiting for perfect evidence before acting. Policymakers often make decisions under conditions of uncertainty. However, those decisions should remain open to review as new evidence emerges.
Good governance therefore requires ongoing scientific assessment, independent research, post-market surveillance, and regular policy evaluation to ensure regulations continue serving their intended public health objectives.
Regulation Should Be Proportionate to Risk
Not all nicotine products are identical.
Products differ in their design, composition, route of administration, manufacturing standards, and patterns of use. Regulatory frameworks should recognise these differences rather than applying identical approaches across every product category.
Risk-proportionate regulation does not imply lighter regulation. Instead, it means calibrating regulatory requirements according to available scientific evidence while maintaining robust protections for consumers and society.
This may include differentiated product standards, manufacturing requirements, ingredient disclosure, packaging rules, marketing restrictions, and market authorisation pathways that reflect the characteristics of individual products.
Such an approach enables regulators to address specific risks while avoiding unnecessary regulatory inconsistency.
Strong Enforcement Gives Regulation Meaning
Even the most carefully designed legislation cannot succeed without effective implementation.
Good governance requires regulatory agencies to have the resources, legal authority, technical expertise, and operational capacity needed to enforce compliance consistently.
This includes monitoring manufacturing standards, inspecting retail outlets, verifying age restrictions, removing non-compliant products from the market, preventing illegal imports, addressing illicit trade, and responding promptly to safety concerns.
Consistent enforcement protects both consumers and legitimate businesses while reducing opportunities for illicit operators to exploit regulatory gaps.
Regulation without enforcement risks becoming little more than policy on paper.
Product Standards Protect Consumers
One of the most important functions of regulation is establishing clear expectations for product quality.
Comprehensive product standards can require manufacturers to comply with manufacturing quality systems, ingredient disclosure, contaminant testing, nicotine-content requirements, child-resistant packaging, accurate labelling, and product traceability.
These standards improve transparency while providing regulators with objective criteria against which products can be assessed.
Rather than relying solely on prohibition, governments can use product standards to influence product quality directly and encourage continuous improvement across regulated markets.
Transparency Builds Public Trust
Public confidence depends upon transparent decision-making.
Regulatory decisions should be supported by clearly communicated evidence, published scientific assessments where appropriate, and explanations that allow stakeholders to understand how policy conclusions were reached.
Transparency also strengthens accountability.
When governments explain the evidence supporting regulatory decisions, publish consultation outcomes, and evaluate the impact of implemented policies, public confidence in regulatory institutions is enhanced even where stakeholders may disagree with individual policy choices.
Transparent governance encourages constructive dialogue rather than unnecessary polarisation.
Stakeholder Engagement Strengthens Better Policy
Good governance should not occur in isolation.
Policymakers benefit from engaging a broad range of stakeholders, including scientists, healthcare professionals, regulators, manufacturers, consumer organisations, retailers, and civil society.
Meaningful consultation does not require governments to adopt every recommendation. Rather, it ensures that diverse expertise informs policy development and helps identify practical implementation challenges before regulations are introduced.
Stakeholder engagement can also improve regulatory compliance by creating greater clarity around expectations and encouraging shared ownership of public health objectives.
Well-designed consultation processes contribute to stronger, more practical regulation.
Youth Protection Must Remain Central
One principle should remain consistent across all nicotine governance frameworks: children and adolescents should not use nicotine products.
Strong youth protections should include effective age verification, responsible retail practices, restrictions on youth-oriented marketing, child-resistant packaging, enforcement against illegal sales, and educational initiatives that discourage nicotine initiation.
Importantly, youth protection should be integrated throughout regulatory systems rather than treated as a standalone policy objective.
Protecting young people strengthens public confidence while supporting the long-term credibility of nicotine regulation.
Governance Must Be Adaptable
Nicotine markets continue to evolve rapidly.
New technologies, changing consumer preferences, scientific discoveries, and international regulatory developments require governance systems that can respond effectively to change.
Adaptive regulation allows governments to review product standards, reassess regulatory requirements, update scientific guidance, and refine enforcement strategies without requiring entirely new legislative frameworks each time innovation occurs.
Flexibility is increasingly becoming one of the defining characteristics of effective governance.
Regulatory systems should be designed not only for today’s products but also for those that may emerge tomorrow.
Measuring Success
The success of nicotine governance should not be judged solely by legislative activity.
A more meaningful assessment considers outcomes.
Has smoking prevalence declined?
Are fewer young people initiating nicotine use?
Have product standards improved?
Has regulatory compliance increased?
Has illicit trade been reduced?
Are consumers receiving accurate information?
Do regulatory agencies have the tools needed to monitor evolving markets?
Answering these questions provides a more comprehensive picture of whether governance is delivering meaningful public health benefits.
Looking Ahead
Nicotine regulation is entering a new era.
The challenge facing governments is no longer simply how to regulate tobacco. It is how to govern an increasingly diverse nicotine marketplace while protecting public health, maintaining scientific integrity, encouraging regulatory accountability, and responding effectively to innovation.
For GINN, good nicotine governance is built upon several enduring principles: science should guide policy, regulation should be proportionate to risk, enforcement should be consistent, product standards should protect consumers, stakeholder engagement should strengthen policymaking, and regulatory systems should remain transparent and adaptable as evidence evolves.
Ultimately, effective governance is not defined by how restrictive regulation becomes. It is defined by whether regulatory systems improve health outcomes, maintain public trust, and provide a stable, evidence-based framework capable of meeting the challenges of an evolving nicotine landscape.
